Display omitted
•Compared to other steel slags, LD-slag suppressed CH4 production in a paddy soil.•LD-slag amendment mitigated CH4 emissions by 17.8–24.0% in submerged paddies.•LD-slag amendment ...decreased inorganic As concentrations in rice grain by 18.3–19.6%.•LD-slag amendment increased grain yield by 10.3–15.2%.
Over the past decades, with increasing steel manufacturing, the huge amount of by-products (slags) generated need to be reused in an efficient way not only to reduce landfill slag sites but also for sustainable and eco-friendly agriculture. Our preliminary laboratory study revealed that compared to blast furnace slag, electric arc furnace slag and ladle furnace slag, the Linz-Donawitz converter (LD) slag markedly decreased CH4 production rate and increased microbial activity. In the greenhouse experiment, the LD slag amendment (2.0 Mg ha−1) significantly (p < 0.05) increased grain yield by 10.3–15.2%, reduced CH4 emissions by 17.8–24.0%, and decreased inorganic As concentrations in grain by 18.3–19.6%, compared to the unamended control. The increase in yield is attributed to the increased photosynthetic rates and increased availability of nutrients to the rice plant. Whereas, the decrease in CH4 emissions could be due to the higher Fe availability in the slag amended soil, which acted as an alternate electron acceptor, thereby, suppressed CH4 emissions. The more Fe-plaque formation which could adsorb more As and the competitive inhibition of As uptake with higher availability of Si could be the reason for the decrease in As uptake by rice cultivated with LD slag amendment.
Data regarding clinical outcomes after intravascular imaging-guided percutaneous coronary intervention (PCI) for complex coronary-artery lesions, as compared with outcomes after angiography-guided ...PCI, are limited.
In this prospective, multicenter, open-label trial in South Korea, we randomly assigned patients with complex coronary-artery lesions in a 2:1 ratio to undergo either intravascular imaging-guided PCI or angiography-guided PCI. In the intravascular imaging group, the choice between intravascular ultrasonography and optical coherence tomography was at the operators' discretion. The primary end point was a composite of death from cardiac causes, target-vessel-related myocardial infarction, or clinically driven target-vessel revascularization. Safety was also assessed.
A total of 1639 patients underwent randomization, with 1092 assigned to undergo intravascular imaging-guided PCI and 547 assigned to undergo angiography-guided PCI. At a median follow-up of 2.1 years (interquartile range, 1.4 to 3.0), a primary end-point event had occurred in 76 patients (cumulative incidence, 7.7%) in the intravascular imaging group and in 60 patients (cumulative incidence, 12.3%) in the angiography group (hazard ratio, 0.64; 95% confidence interval, 0.45 to 0.89; P = 0.008). Death from cardiac causes occurred in 16 patients (cumulative incidence, 1.7%) in the intravascular imaging group and in 17 patients (cumulative incidence, 3.8%) in the angiography group; target-vessel-related myocardial infarction occurred in 38 (cumulative incidence, 3.7%) and 30 (cumulative incidence, 5.6%), respectively; and clinically driven target-vessel revascularization in 32 (cumulative incidence, 3.4%) and 25 (cumulative incidence, 5.5%), respectively. There were no apparent between-group differences in the incidence of procedure-related safety events.
Among patients with complex coronary-artery lesions, intravascular imaging-guided PCI led to a lower risk of a composite of death from cardiac causes, target-vessel-related myocardial infarction, or clinically driven target-vessel revascularization than angiography-guided PCI. (Supported by Abbott Vascular and Boston Scientific; RENOVATE-COMPLEX-PCI ClinicalTrials.gov number, NCT03381872).
The effective utilization of slag-based Silicon fertilizer (silicate fertilizer) in agriculture to improve crop productivity and to mitigate environmental consequences turns it into a high value ...added product in sustainable agriculture. Despite the integral role of soil microbiome in agricultural production and virtually all ecosystem processes, our understanding of the microbial role in ecosystem functions and agricultural productivity in response to the silicate fertilizer amendment is, however, elusive. In this study, using 16S rRNA gene and ITS amplicon illumina sequencing and a functional gene microarray, i.e., GeoChip 5, we report for the first time the responses of soil microbes and their functions to the silicate fertilizer amendment in two different geographic races of Oryza sativa var. Japonica (Japonica rice) and var. Indica (Indica rice). The silicate fertilizer significantly increased soil pH, photosynthesis rate, nutrient (i.e., C, Si, Fe, P) availability and crop productivity, but decreased N availability and CH4 and N2O emissions. Moreover, the silicate fertilizer application significantly altered soil bacterial and fungal community composition and increased abundance of functional genes involved in labile C degradation, C and N fixation, phosphorus utilization, CH4 oxidation, and metal detoxification, whereas those involve in CH4 production and denitrification were decreased. The changes in the taxonomic and functional structure of microbial communities by the silicate fertilizer were mostly regulated by soil pH, plant photosynthesis, and nutrient availability. This study provides novel insights into our understanding of microbial functional processes in response to the silicate fertilizer amendment in rice cropping systems and has important implications for sustainable rice production.
Display omitted
•Silicate fertilization increased abundance of genes involved in labile C degradation.•Silicate fertilization increased gene abundance for C and N fixation.•Silicate fertilization significantly decreased gene (mcrA) abundance for methanogen.•It significantly increased gene (pmoA) abundance for methanotroph.•Silicate fertilization significantly increased metal detoxifying gene abundance.
Biochar emerged as a potential solution to mitigating greenhouse gas emissions, though previous studies obtained variable results regarding its effects on methane (CH4) emissions and crop yields. ...Global meta-analyses were conducted regarding the effectiveness of biochar, though regional meta-analyses are still needed. We performed a meta-analysis of 43 published papers to obtain the central tendency of the response to biochar application in East Asian rice paddies. Biochar application significantly reduced methane emissions while increasing the soil organic carbon (SOC) content and crop yield. We identified the most significant influencing factors on the CH4 emissions, SOC content, and crop yield. Our findings provide a scientific basis for the application of biochar to East Asian rice paddies, as well as to study the effects of biochar application in East Asian rice paddies. The numbers in parentheses represent the sample sizes.
Biochar application has been considered as a promising solution to address the effects of modern agriculture on climate change. However, there is a lack of research on the biochar application of ...greenhouse gas emissions based on poor soils in Korean agricultural land. Therefore, this study aimed to evaluate the effects of biochar application according to different soil characteristics on soil organic carbon (SOC) improvement and greenhouse gas reduction. The incubation experiments were conducted for 49 days and used different feedstock (barley straw and poultry manure) and biochar application rates (0, 5, 10, and 20-ton ha−1) in four soil characteristics (upland, U; greenhouse, G; converted land, C; reclaimed land, R). The results of this study showed that the SOC increased significantly in all soils after biochar application. The increasing SOC rate was the highest in poor soil. Biochar 20-ton ha−1 treatment significantly reduced N2O emissions by 33.2% compared with the control. Barley straw biochar significantly reduced N2O emissions from all soils. Barley straw biochar decreased approximately 74.5% of N2O emissions compared with poultry manure biochar. Poultry manure biochar improved SOC and reduced N2O emissions in poor soil. However, in poultry manure biochar treatment in U and G soil, N2O emissions increased. In conclusion, barley straw biochar application was found to suppress N2O emissions and improve the SOC in all soil characteristics of agricultural land. In addition, the soil carbon storage effect and N2O reduction effect of biochar were the highest in poor soil. Thus, the biochar application can be a potential agricultural practice for improving soil quality and decreasing N2O emissions in domestic agricultural soil.
It is unclear whether the beneficial effects of intravascular imaging–guided stent optimization vary by clinical presentation during complex percutaneous coronary intervention (PCI).
In this ...prespecified, stratified subgroup analysis from RENOVATE-COMPLEX-PCI (Randomized Controlled Trial of Intravascular Imaging Guidance versus Angiography-Guidance on Clinical Outcomes After Complex PCI), we sought to compare the outcomes between intravascular imaging vs angiography guidance according to clinical presentation.
Patients with complex coronary artery lesions were randomly assigned to undergo either intravascular imaging–guided PCI or angiography-guided PCI in a 2:1 ratio. The primary endpoint was target vessel failure (TVF), which is a composite of cardiac death, target vessel–related myocardial infarction, or clinically driven target vessel revascularization.
Of 1,639 patients, 832 (50.8%) presented with acute coronary syndrome (ACS) and 807 (49.2%) with chronic coronary syndrome. During a median follow-up of 2.1 years (Q1-Q3: 1.4-3.0 years), there was no significant interaction between the treatment effect of intravascular imaging and clinical presentation (P for interaction = 0.19). Among patients with ACS, the incidences of TVF were 10.4% in the intravascular imaging group and 14.6% in the angiography group (HR: 0.74; 95% CI: 0.48-1.15; P = 0.18). Among patients with CCS, the incidences of TVF were 5.0% in the intravascular imaging group and 10.4% in the angiography group (HR: 0.46; 95% CI: 0.27-0.80; P = 0.006). Achieving stent optimization by intravascular imaging resulted in a reduced risk of TVF among patients with ACS who were randomly assigned to intravascular imaging–guided PCI for complex coronary lesions (optimized vs unoptimized, 6.5% vs 14.1%; HR: 0.49; 95% CI: 0.27-0.87; P = 0.02) but not those with CCS (5.4% vs 4.7%, HR: 1.18; 95% CI: 0.53-2.59; P = 0.69).
No significant interaction was observed between the benefits of intravascular imaging and clinical presentation in the risk of TVF. Stent optimization by intravascular imaging was particularly important for ACS patients. (Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease RENOVATE; NCT03381872)
Display omitted
Although benefits of intravascular imaging (IVI) in percutaneous coronary intervention (PCI) have been observed in previous studies, it is not known whether changes in contemporary practice, ...especially with application of standardized optimization protocols, have improved clinical outcomes.
The authors sought to investigate whether clinical outcomes of IVI-guided PCI are different before and after the application of standardized optimization protocols in using IVI.
2,972 patients from an institutional registry (2008-2015, before application of standardized optimization protocols, the past group) and 1,639 patients from a recently published trial (2018-2021 after application of standardized optimization protocols, the present group) were divided into 2 groups according to use of IVI. The primary outcome was 3-year target vessel failure (TVF), a composite of cardiac death, target vessel myocardial infarction, or target vessel revascularization.
Significant reduction of TVF was observed in the IVI-guided PCI group compared with the angiography-guided PCI group (10.0% vs 6.7%; HR: 0.77; 95% CI: 0.61-0.97; P = 0.027), mainly driven by reduced cardiac death or myocardial infarction in both past and present IVI-guided PCI groups. When comparing past IVI and present IVI groups, TVF was significantly lower in the present IVI group (8.5% vs 5.1%; HR: 0.63; 95% CI: 0.42-0.94; P = 0.025), with the difference being driven by reduced target vessel revascularization in the present IVI group. Consistent results were observed in inverse-probability-weighting adjusted analysis.
IVI-guided PCI improved clinical outcomes more than angiography-guided PCI. In addition, application of standardized optimization protocols when using IVI further improved clinical outcomes after PCI. (Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease RENOVATE-COMPLEX-PCI; NCT03381872; and the institutional cardiovascular catheterization database of Samsung Medical Center: Long-Term Outcomes and Prognostic Factors in Patient Undergoing CABG or PCI; NCT03870815).
The RENOVATE-COMPLEX-PCI (Randomized Controlled Trial of Intravascular Imaging Guidance Versus Angiography-Guidance on Clinical Outcomes After Complex Percutaneous Coronary Intervention) demonstrated ...that intravascular imaging-guided percutaneous coronary intervention (PCI) improved clinical outcome compared with angiography-guided PCI for patients with complex coronary artery lesions. This study aims to assess whether the prognostic benefit of intravascular imaging-guided procedural optimization persists in patients undergoing PCI for left main coronary artery disease.
Of 1639 patients enrolled in the RENOVATE-COMPLEX-PCI, 192 patients with left main coronary artery disease were selected for the current prespecified substudy. Selected patients were randomly assigned to either the intravascular imaging-guided PCI group (n=138) or the angiography-guided PCI group (n=54). The primary end point was target vessel failure defined as a composite of cardiac death, target vessel-related myocardial infarction, or clinically driven target vessel revascularization.
At a median follow-up of 2.1 years (interquartile range 1.1 to 3.0 years), intravascular imaging-guided PCI was associated with lower incidence of primary end point compared with angiography-guided PCI (6.8% versus 25.1%; hazard ratio, 0.31 95% CI, 0.13-0.76;
=0.010). This significant reduction in primary end point was mainly driven by a lower risk of cardiac death or spontaneous target vessel-related myocardial infarction (1.6% versus 12.7%; hazard ratio, 0.16 95% CI, 0.03-0.82;
=0.028). Intravascular imaging-guided PCI was independently associated with a lower risk of primary end point, even after adjusting for various clinical factors (hazard ratio, 0.29 95% CI, 0.12-0.72;
=0.007).
Intravascular imaging-guided PCI showed clinical benefit over angiography-guided PCI for left main coronary artery disease in reducing the risk of cardiac death, target vessel-related myocardial infarction, or target vessel revascularization.
URL: https://www.clinicaltrials.gov; Unique identifier: NCT03381872.
Although clinical benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) in patients with complex coronary artery lesions have been observed in previous trials, the ...cost-effectiveness of this strategy is uncertain.
RENOVATE-COMPLEX-PCI (Randomized Controlled Trial of Intravascular Imaging Guidance vs Angiography-Guidance on Clinical Outcomes After Complex Percutaneous Coronary Intervention) was conducted in Korea between May 2018 and May 2021. This prespecified cost-effectiveness substudy was conducted using Markov model that simulated 3 states: (1) post-PCI, (2) spontaneous myocardial infarction, and (3) death. A simulated cohort was derived from the intention-to-treat population, and input parameters were extracted from either the trial data or previous publications. Cost-effectiveness was evaluated using time horizon of 3 years (within trial) and lifetime. The primary outcome was incremental cost-effectiveness ratio (ICER), an indicator of incremental cost on additional quality-adjusted life years (QALYs) gained, in intravascular imaging-guided PCI compared with angiography-guided PCI. The current analysis was performed using the Korean health care sector perspective with reporting the results in US dollar (1200 Korean Won, ₩=1 dollar, $). Willingness to pay threshold was $35 000 per QALY gained.
A total of 1639 patients were included in the trial. During 3-year follow-up, medical costs ($8661 versus $7236; incremental cost, $1426) and QALY (2.34 versus 2.31; incremental QALY, 0.025) were both higher in intravascular imaging-guided PCI than angiography-guided PCI, resulting incremental cost-effectiveness ratio of $57 040 per QALY gained within trial data. Conversely, lifetime simulation showed total cumulative medical cost was reversed between the 2 groups ($40 455 versus $49 519; incremental cost, -$9063) with consistently higher QALY (8.24 versus 7.89; incremental QALY, 0.910) in intravascular imaging-guided PCI than angiography-guided PCI, resulting in a dominant incremental cost-effectiveness ratio. Consistently, 70% of probabilistic iterations showed cost-effectiveness of intravascular imaging-guided PCI in probabilistic sensitivity analysis.
The current cost-effectiveness analysis suggests that imaging-guided PCI is more cost-effective than angiography-guided PCI by reducing medical cost and increasing quality-of-life in complex coronary artery lesions in long-term follow-up.
URL: https://www.clinicaltrials.gov; Unique identifier: NCT03381872.
PDF
